Board of directors

DGAP-News: Cureus confirms further project starts and completions in the second quarter of 2022

Retrieved on: 
Wednesday, July 6, 2022 - 7:04am

Oliver Sturhahn, CFO of Cureus: Cureus is on a very sound financial footing, which is of great importance given the current market environment.

Key Points: 
  • Oliver Sturhahn, CFO of Cureus: Cureus is on a very sound financial footing, which is of great importance given the current market environment.
  • More about the project
    The Insanto senior residence in Dinslaken (North Rhine-Westphalia) marked the completion of another Cureus project in the second quarter of 2022.
  • More about the project
    Numerous ground-breaking and topping-out ceremonies were also held during the second quarter of 2022.
  • Visualisation WH Care life and health centre Haus Momentum, front of the bilding, Hammah, Lower Saxony, a Cureus Project

DENTSPLY SIRONA INC. (NASDAQ: XRAY) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against DENTSPLY SIRONA Inc. (NASDAQ: XRAY)

Retrieved on: 
Wednesday, July 6, 2022 - 6:30am

NEW YORK, July 06, 2022 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the common stock of Dentsply Sirona, Inc. (“Dentsply” or the “Company”) (NASDAQ: XRAY) between June 9, 2021 and May 9, 2022, inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the Southern District of Ohio and alleges violations of the Securities Exchange Act of 1934.

Key Points: 
  • Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com to discuss your rights.
  • Dentsply produces a wide array of dental supplies, ranging from anesthetics, plaque and gum disease prevention, tooth polishers, and artificial teeth.
  • As (former) executives of Dentsply, Defendants Donald M. Casey, Jr. (Casey) and Jorge Gomez (Gomez) were eligible for significant cash- and stock-based incentive compensation.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

BiomX Announces Voluntary Delisting from the Tel Aviv Stock Exchange

Retrieved on: 
Wednesday, July 6, 2022 - 6:45am

BiomX Inc. (NYSE American: PHGE) (BiomX or the Company), a clinical-stage microbiome company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, announced today that it is voluntarily delisting its shares of common stock from trading on the Tel Aviv Stock Exchange (the TASE).

Key Points: 
  • BiomX Inc. (NYSE American: PHGE) (BiomX or the Company), a clinical-stage microbiome company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, announced today that it is voluntarily delisting its shares of common stock from trading on the Tel Aviv Stock Exchange (the TASE).
  • Under applicable Israeli law, the delisting of BiomXs shares of common stock from trading on the TASE is expected to become effective in three months, on October 6, 2022.
  • BiomX is a clinical-stage microbiome company developing both natural and engineered phage cocktails designed to target and destroy bacteria in the treatment of chronic diseases.
  • For example, when BiomX discusses its expectations regarding the timing and benefits of delisting from TASE and expectation of continued listing on the NYSE American, BiomX is making forward-looking statements.

Paramount Gold Strengthens Its Board of Directors With the Appointment of Samantha Espley

Retrieved on: 
Tuesday, July 5, 2022 - 9:30pm

WINNEMUCCA, Nev., July 05, 2022 (GLOBE NEWSWIRE) -- Paramount Gold Nevada Corp. (NYSE American: PZG) (Paramount or the Company) announced today that Samantha Espley, P.Eng.

Key Points: 
  • WINNEMUCCA, Nev., July 05, 2022 (GLOBE NEWSWIRE) -- Paramount Gold Nevada Corp. (NYSE American: PZG) (Paramount or the Company) announced today that Samantha Espley, P.Eng.
  • Paramount Chairman, Rudi Fronk, commented on the appointment: Samantha is joining our board at a critical time as we approach permitting approval for our underground Grassy Mountain gold mine.
  • About Paramount Gold Nevada Corp.
    Paramount Gold Nevada Corp. is a U.S. based precious metals exploration and development company.
  • With higher gold prices, Paramount has begun work to update and improve the economics of the Sleeper project.

Safe Bulkers, Inc. Declares Quarterly Dividend on its 8.00% Series C Cumulative Redeemable Perpetual Preferred Shares; 8.00% Series D Cumulative Redeemable Perpetual Preferred Shares.

Retrieved on: 
Tuesday, July 5, 2022 - 9:05pm

Each dividend will be paid on August 1, 2022 to all shareholders of record as of July 22, 2022 of the Series C Preferred Shares and of the Series D Preferred Shares, respectively.

Key Points: 
  • Each dividend will be paid on August 1, 2022 to all shareholders of record as of July 22, 2022 of the Series C Preferred Shares and of the Series D Preferred Shares, respectively.
  • The declaration and payment of future dividends, if any, will always be subject to the discretion of the Board of Directors of the Company.
  • There is no guarantee that the Companys Board of Directors will determine to issue cash dividends in the future.
  • The Company's common stock, Series C and Series D preferred stock is listed on the NYSE, where it trades under the symbols SB, SB.PR.C and SB.PR.D, respectively.

Macquarie Global Infrastructure Total Return Fund Inc. Announces Monthly Distribution

Retrieved on: 
Tuesday, July 5, 2022 - 9:54pm

The Board of Directors of Macquarie Global Infrastructure Total Return Fund Inc. (NYSE:MGU) (Fund) declared on July 5, 2022, a regular distribution for the month ending June 30, 2022 of $0.13 per share.

Key Points: 
  • The Board of Directors of Macquarie Global Infrastructure Total Return Fund Inc. (NYSE:MGU) (Fund) declared on July 5, 2022, a regular distribution for the month ending June 30, 2022 of $0.13 per share.
  • Macquarie Global Infrastructure Total Return Fund Inc., a diversified closed-end fund, is listed on the New York Stock Exchange.
  • The Funds investment adviser is Delaware Management Company (Investment Adviser), a series of Macquarie Investment Management Business Trust, which is a subsidiary of Macquarie Management Holdings, Inc. (MMHI).
  • Macquarie Asset Management (MAM) is the asset management division of Macquarie Group.

Ellsworth Growth and Income Fund Ltd. Announces the Placement of $25 Million of Series B Cumulative Preferred Shares

Retrieved on: 
Tuesday, July 5, 2022 - 9:36pm

The Board of Trustees of Ellsworth Growth and Income Fund Ltd. (NYSE American: ECF) (the Fund) is pleased to announce the issuance of Series B Cumulative Preferred Shares (Series B Preferred) with an aggregate liquidation value of approximately $25 million.

Key Points: 
  • The Board of Trustees of Ellsworth Growth and Income Fund Ltd. (NYSE American: ECF) (the Fund) is pleased to announce the issuance of Series B Cumulative Preferred Shares (Series B Preferred) with an aggregate liquidation value of approximately $25 million.
  • The Series B Preferred is puttable on June 26, 2023 and June 26, 2024, and is callable after June 26, 2024.
  • Distributions are at an annual rate of 4.40% of the $10.00 per share liquidation preference of the Series B Preferred and are scheduled to be paid semiannually beginning on December 26, 2022.
  • For more information about the Fund, call:
    Ellsworth Growth and Income Fund Ltd. is a diversified, closed-end management investment company with $191 million in total net assets.

Cerus Corporation Announces Appointment of Hua Shan, MD, PhD to Board of Directors

Retrieved on: 
Tuesday, July 5, 2022 - 10:00pm

Cerus Corporation (Nasdaq: CERS) today announced the appointment of Hua Shan, MD, PhD, Professor of Pathology and Medical Director, Transfusion Medicine Service at Stanford Medical Center to its Board of Directors.

Key Points: 
  • Cerus Corporation (Nasdaq: CERS) today announced the appointment of Hua Shan, MD, PhD, Professor of Pathology and Medical Director, Transfusion Medicine Service at Stanford Medical Center to its Board of Directors.
  • We are pleased to welcome Dr. Shan to Cerus Board of Directors, said Daniel Swisher, Chair of the Board.
  • I am delighted to be joining the Board of Directors at Cerus during this exciting time in the Companys history, said Dr. Shan.
  • Cerus Corporation is dedicated solely to safeguarding the worlds blood supply and aims to become the preeminent global blood products company.

Luxfer Declares Quarterly Dividend and Announces Date of Second Quarter Earnings Release

Retrieved on: 
Tuesday, July 5, 2022 - 9:30pm

The dividend will be payable on August 3, 2022 to shareholders of record as of the close of business on July 15, 2022.

Key Points: 
  • The dividend will be payable on August 3, 2022 to shareholders of record as of the close of business on July 15, 2022.
  • All holders of NYSE-listed ordinary shares will be paid in U.S. dollars through the Companys dividend disbursing agent.
  • For holders of ordinary shares not directly listed on the New York Stock Exchange, the dividend will be paid directly by the Company.
  • The Company also announced that it will release financial results for the second quarter of 2022 after market closes on Tuesday, July 26, 2022.

Ambrx Biopharma Appoints Edward Hu and Kate Hermans to its Board of Directors

Retrieved on: 
Tuesday, July 5, 2022 - 9:05pm

Ambrx Biopharma Inc., or Ambrx, (NYSE: AMAM), a clinical stage biopharmaceutical company using an expanded genetic code technology platform to create Engineered Precision Biologics (EPBs), today announced the appointments of Edward Hu and Kate Hermans to its Board of Directors.

Key Points: 
  • Ambrx Biopharma Inc., or Ambrx, (NYSE: AMAM), a clinical stage biopharmaceutical company using an expanded genetic code technology platform to create Engineered Precision Biologics (EPBs), today announced the appointments of Edward Hu and Kate Hermans to its Board of Directors.
  • I am delighted to welcome both Edward and Kate to Ambrxs Board, said Feng Tian, Ph.
  • Edward Hu has more than 25 years experience in the pharmaceutical industry.
  • Ms. Hermans is a Board Director on the Advisory Board of Clue and serves on the Board of Mid-Atlantic Diamond Ventures.